10,000
Participants
Start Date
January 11, 2023
Primary Completion Date
January 31, 2050
Study Completion Date
January 31, 2055
Data collection
The data collection includes, among other things: Diagnosis of the rare tumor (pathological findings/ reference pathological findings), full name, birth date, gender, clinical registry inclusion and exclusion criteria met - yes / no, signed declaration of consent-yes / no, if yes: date of signature
RECRUITING
University Hospital Tübingen, Tübingen
University Hospital Tuebingen
OTHER